| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787197 | European Journal of Surgical Oncology (EJSO) | 2017 | 6 Pages |
Abstract
Implementing a PIPAC program in association with systemic chemotherapy is feasible and is associated with a risk of postoperative morbidity, even in teams highly experienced in PC management and requires a learning curve in patient selection.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mohammad Alyami, Johan Gagniere, Olivia Sgarbura, Delphine Cabelguenne, Laurent Villeneuve, Denis Pezet, Francois Quenet, Olivier Glehen, Naoual Bakrin, Guillaume Passot,